Literature DB >> 18006306

Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.

Richard M Angell1, Paul Bamborough, Anne Cleasby, Stuart G Cockerill, Katherine L Jones, Christopher J Mooney, Donald O Somers, Ann L Walker.   

Abstract

The biphenyl amides (BPAs) are a novel series of p38 MAP kinase inhibitors. The discovery of the series through structure-based focused screening is described, and the binding mode of the compounds is explained with reference to X-ray crystal structures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006306     DOI: 10.1016/j.bmcl.2007.10.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinase.

Authors:  Christopher N Johnson; Valerio Berdini; Lijs Beke; Pascal Bonnet; Dirk Brehmer; Joseph E Coyle; Phillip J Day; Martyn Frederickson; Eddy J E Freyne; Ron A H J Gilissen; Christopher C F Hamlett; Steven Howard; Lieven Meerpoel; Rachel McMenamin; Sahil Patel; David C Rees; Andrew Sharff; François Sommen; Tongfei Wu; Joannes T M Linders
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

2.  An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.

Authors:  So-Young Kim; Hong Kim; Sang-Won Kim; Na-Rae Lee; Chae-Min Yi; Jinyuk Heo; Bum-Joon Kim; Nam-Jung Kim; Kyung-Soo Inn
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  3D-QSAR and molecular docking analysis of biphenyl amide derivatives as p38α mitogen-activated protein kinase inhibitors.

Authors:  Pravin Sundarao Ambure; Rahul Prakashchand Gangwal; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2012-01-07       Impact factor: 2.943

4.  CrystalDock: a novel approach to fragment-based drug design.

Authors:  Jacob D Durrant; Aaron J Friedman; J Andrew McCammon
Journal:  J Chem Inf Model       Date:  2011-10-05       Impact factor: 4.956

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.